03183nam 2200553 450 991078640800332120230801233131.088-97419-38-0(CKB)3710000000118109(EBL)3034683(SSID)ssj0001399525(PQKBManifestationID)11820535(PQKBTitleCode)TC0001399525(PQKBWorkID)11458804(PQKB)11621819(MiAaPQ)EBC3034683(Au-PeEL)EBL3034683(CaPaEBR)ebr10960569(OCoLC)881727882(EXLCZ)99371000000011810920141106d2012 uy| 0engurcnu||||||||txtccrPharmacoeconomics principles and practice /Lorenzo Pradelli, Albert WertheimerFirst edition.Torino, Italy :SEEd,2012.1 online resource (125 p.)Description based upon print version of record.88-97419-37-2 Includes bibliographical references.""Title Page""; ""Colophon ""; ""Table of Contents""; ""Preface""; ""Introduction""; ""Health Care Dilemma""; ""Opportunity Cost""; ""Efficiency and Equity""; ""Pharmacoeconomics""; ""Sensitivity Analysis""; ""Summary""; ""Further Readings""; ""1 Definitions and Basic Concepts""; ""1.1 Definitions""; ""1.2 Costs""; ""1.3 Consequences""; ""1.4 Perspectives""; ""1.5 Time Horizon""; ""2 Pharmacoeconomic Evaluations""; ""2.1 Introduction""; ""2.2 Cost Analysis""; ""2.3 Cost-outcomes Analysis""; ""2.4 Utility""; ""2.5 Psychometrics""; ""3 Modeling Frameworks""; ""3.1 Steps in Decision Analysis""""3.2 Influence Diagrams""""3.3 Markov Models""; ""3.4 Discrete-event Simulation""; ""3.5 Agent-based Models""; ""4 Budget Impact Analysis""; ""4.1 Introduction""; ""4.2 Example: Budget Impact Analysis of Clinical Guidelines in COPD Patients""; ""5 Patient Reported Outcomes""; ""5.1 Introduction""; ""5.2 From Biological Measures to Patient Reported Outcome""; ""5.3 Quality of Life, Health Related Quality of Life, and Patient Reported Outcomes""; ""5.4 PRO Dimensions""; ""5.5 Every Patient has Individual Health Perceptions""; ""5.6 Applications of PRO Instruments""""5.7 Identifying an Appropriate Instrument for Measuring PRO""""5.8 PRO Instruments""; ""5.9 When are the Results of PROs Relevant?""; ""5.10 Summary and Conclusion""; ""6 Data Sources and Accounting for Uncertainty""; ""6.1 Data Sources""; ""6.2 Statistical Analysis""; ""6.3 Accounting for Uncertainty""; ""6.4 Pharmacoeconomic Studies""; ""6.5 Conclusions: Evaluating Pharmacoeconomic Studies""; ""References""; ""Glossary""; ""Authors""DrugsCost effectivenessPharmacyEconomic aspectsDrugsCost effectiveness.PharmacyEconomic aspects.Pradelli Lorenzo1483693Wertheimer AlbertMiAaPQMiAaPQMiAaPQBOOK9910786408003321Pharmacoeconomics3701967UNINA